Thailand Approves Third Covid-19 Vaccine for Emergency Use from Johnson & Johnson
Thailand Approves Third Covid-19 Vaccine for Emergency Use from Johnson & Johnson
Thailand Approves Third Covid-19 Vaccine for Emergency Use from Johnson & Johnson
25 มี.ค. 2564

The Food and Drug Administration on March 25, 2021, granted the emergency use authorization for Johnson &amp; Johnson Covid-19 vaccine, making it the third vaccine to be approved for use in Thailand.
 
J&amp;J’s vaccine showed 86% efficacy against severe forms of Covid-19 in the United States, and 82% against severe variants in South Africa.
More importantly, J&amp;J’s vaccine requires only one dose, making logistics much easier as well as more convenient for the patients.